🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 7 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/04/2017 59,50 59,76 59,04 59,06 -1,06% 1,22% 11.002.323
20/04/2017 59,79 59,88 59,40 59,69 -0,14% 0,80% 9.392.490
19/04/2017 59,41 59,77 59,16 59,77 +0,59% 1,03% 10.845.857
18/04/2017 59,60 59,60 59,15 59,42 -0,84% 0,75% 7.749.436
17/04/2017 59,84 59,96 59,53 59,92 +0,30% 0,72% 5.590.242
13/04/2017 59,91 60,11 59,69 59,74 -0,70% 0,70% 6.217.260
12/04/2017 59,51 60,31 59,43 60,16 +0,75% 1,49% 9.965.642
11/04/2017 59,63 59,89 59,33 59,71 +0,05% 0,93% 6.858.950
10/04/2017 60,37 60,43 59,67 59,69 -0,92% 1,26% 7.595.590
07/04/2017 60,38 60,43 60,07 60,24 -0,17% 0,60% 8.091.713
06/04/2017 60,57 61,04 60,30 60,34 -0,52% 1,23% 7.915.125
05/04/2017 60,77 61,21 60,60 60,66 -0,16% 1,00% 8.083.538
04/04/2017 60,68 60,85 60,47 60,75 +0,32% 0,63% 6.650.189
03/04/2017 60,52 60,79 60,32 60,56 -0,11% 0,77% 6.962.493
31/03/2017 60,36 60,72 60,35 60,63 +0,14% 0,60% 7.979.472
30/03/2017 60,59 60,76 60,42 60,54 -0,30% 0,57% 5.577.456
29/03/2017 60,75 61,17 60,55 60,73 +0,47% 1,02% 8.525.794
28/03/2017 60,31 60,50 60,00 60,44 +0,24% 0,82% 10.673.880
27/03/2017 60,04 60,51 59,93 60,30 +0,02% 0,95% 8.400.663
24/03/2017 60,27 60,62 59,98 60,29 -0,16% 1,06% 9.575.052
23/03/2017 60,46 60,90 60,30 60,38 -0,35% 0,99% 9.915.128
22/03/2017 61,05 61,17 60,35 60,59 -0,64% 1,34% 10.007.352
21/03/2017 61,37 61,65 60,71 60,98 -0,31% 1,54% 11.057.134
20/03/2017 61,20 61,36 61,07 61,17 +0,33% 0,47% 13.593.818
17/03/2017 61,31 61,74 60,96 60,97 -0,44% 1,26% 15.142.762
16/03/2017 61,61 61,82 61,06 61,24 -0,80% 1,24% 10.074.634
15/03/2017 61,45 61,99 61,28 61,74 +0,78% 1,16% 9.458.200
14/03/2017 61,19 61,56 61,12 61,26 +0,08% 0,72% 8.271.759
13/03/2017 62,25 62,30 61,08 61,21 -2,21% 1,96% 14.880.133
10/03/2017 63,04 63,17 62,50 62,60 -0,44% 1,06% 9.247.447